Celltrion secures $730 mn to buy biosimilar unit shares, pursue M&A
Celltrion Holdings Co. has secured 1 trillion won ($732 million) in fresh funding and plans to spend half of it this year to buy shares in its biosi...
Korean commercial act revision to drive reevaluation of equities: J.P. Morgan
J.P. Morgan, a leading US investment bank, has thrown its weight behind South Korea’s landmark commercial act revision, saying that the new go...
S.Korean game developer Krafton acquires Japan’s ADK for $517 million
Krafton Inc., a major South Korean game publisher, has acquired Japan's leading advertising and animation group ADK for 75 billion yen ($517 million...
S.Korea’s Lee, Japan’s Ishiba agree to deepen ties, resume shuttle diplomacy
KANANASKIS, Canada – South Korea’s newly elected President Lee Jae-myung held his first summit with Japanese Prime Minister Shigeru Ishi...
Celltrion shares rise after bonus issue announcement
Celltrion Inc., South Korea’s largest biosimilar developer, will issue bonus shares to bolster its stock performance, which has been in the do...
CJ CheilJedang to open $72 million dumpling plant in Japan
South Korea’s largest food company, CJ CheilJedang Corp., is shifting into high gear in its global expansion with a 100 billion won ($72 milli...
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Seoul mulls joint review of Alaska LNG project with Japan, Taiwan, Vietnam
South Korea has proposed forming a consortium with Japan, Taiwan and Vietnam to jointly assess the feasibility of investing in the $45 billion Alask...
Kyobo Life poised to buy Japan’s SBI Group-owned savings bank
Kyobo Life Insurance Co. is in the final stages of negotiation with Japanese financial group SBI Holdings Inc. to buy about a 50% stake in SBI Savin...
Shinhan to lead financing for battery storage project in Japan
Shinhan Financial Group will lead 4.9 billion yen ($35 million) in financing for a large-scale battery energy storage system (BESS) construction pro...
Celltrion expands footprint in Latin America with flagship oncology drugs
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
LG Energy Solution clinches multibillion-dollar ESS deals in Japan, Europe
LG Energy Solution Ltd. has secured a string of billion-dollar energy storage system (ESS) deals in Japan and Europe, outmaneuvering Chinese rivals ...
S.Korean shipbuilders rally as Trump hints at buying foreign ships
South Korean shipbuilding stocks soared on Friday on news that US President Donald Trump indicated that the world’s No. 1 economy may purchase...
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
China says it is aiming to coordinate tariff response with Japan, South Korea
.video-container { position: relative; padding-bottom: 56.25%; padding-top: 30px; height: 0; overflow: hidden; } .video-container ifr...
K-pop exports boom as end of Chinese K-wave ban looms large
Exports of Korean popular music, or K-pop, have seen a significant surge in recent months, driven by increasing demand from China and Japan, accordi...
Korea, China, Japan resume FTA talks after 6-year hiatus
South Korea held an economic ministers’ meeting with China and Japan on Sunday to discuss cooperation, including resuming negotiations about a...
Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
POSCO to sell entire stake in Nippon Steel, ending equity ties
POSCO Holdings Inc. has decided to sell its entire stake in Nippon Steel Corp., according to industry sources on Wednesday, marking the end of their...
S.Korea courts active funds for $140 bn treasury issuance
South Korea’s finance ministry will hold its largest-ever investor relations (IR) event for global institutional investors at the end of this ...
Celltrion to cancel $140 mn in treasury shares, stock up
South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...
LX Pantos acquires logistics center near Atlanta for $120 mn
LX Pantos Co., a logistics arm of LX International Corp., announced on Tuesday it has acquired a logistics center near Atlanta in Dalton, Georgia fo...
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Korea to probe Chinese, Japanese steel imports over anti-dumping claims
South Korea is set to launch an anti-dumping investigation into hot-rolled steel imports from China and Japan, according to government and industry ...
PAG raises $4 bn for opportunistic Asia real estate fund
PAG, an Asia Pacific-focused alternative investment firm, on Friday announced the final close of its 10th opportunistic real estate fund at $4 billi...
HD Hyundai, Hanwha to tap into $242 billion US Navy warship market
South Korea’s two warship builders – HD Hyundai Heavy Industries Co. and Hanwha Ocean Co., – are set to ride tailwinds in their bi...
MBK-led consortium to take over Japan’s FICT for $656 mn
MBK Partners, the largest private equity firm in North Asia, will acquire a controlling stake in FICT Ltd., a semiconductor printed circuit board (P...
Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
LX Pantos enters US intermodal logistics market with Japan’s ONE
LX Pantos Co., South Korea’s largest logistics company under LX International Corp., has advanced into the US intermodal logistics market join...
